Overview
Deficiency of glutathione reductase (NAD(P)H), while not directly addressed in the provided abstracts, can be inferred to involve impaired redox balance due to dysfunctional glutathione metabolism. This condition is not explicitly detailed in the given sources, which focus more on related enzyme deficiencies in plants and human phosphoribosyltransferases.Diagnosis
Enzyme Activity Assays: Measurement of glutathione reductase activity in erythrocytes or relevant tissues [implied, no direct source].
Genetic Testing: Identification of mutations in the GR gene through molecular analysis [implied, no direct source].
Biochemical Markers: Elevated oxidative stress markers (e.g., oxidized glutathione) may indicate deficiency [implied, no direct source].Management
Supplementation: Oral supplementation with glutathione precursors like N-acetylcysteine (NAC) to support glutathione synthesis [implied, no direct source].
Antioxidants: Use of systemic antioxidants to mitigate oxidative stress [implied, no direct source].
Dietary Adjustments: Encourage a diet rich in sulfur-containing amino acids to support glutathione production [implied, no direct source].Special Populations
Pregnancy: Limited data; cautious monitoring of oxidative stress and supplementation with NAC may be considered [implied, no direct source].
Pediatrics: Early intervention with antioxidant support and dietary modifications is crucial [implied, no direct source].
Elderly: Increased susceptibility to oxidative damage; regular monitoring and tailored antioxidant therapy recommended [implied, no direct source].
Comorbidities: Patients with concurrent oxidative stress-related conditions may require more aggressive antioxidant management [implied, no direct source].Key Recommendations
Genetic Counseling: Offer genetic counseling to affected individuals and families due to potential hereditary nature [implied, no direct source] (Evidence: Expert opinion).
Monitor Oxidative Stress: Regularly assess oxidative stress markers in patients to guide treatment adjustments [implied, no direct source] (Evidence: Expert opinion).
Supportive Therapy: Implement supportive therapies including antioxidant supplementation and dietary modifications to manage symptoms [implied, no direct source] (Evidence: Expert opinion).References
1 Schoenmakers HC, Koornneef M, Alefs SJ, Gerrits WF, van der Kop D, Chérel I et al.. Isolation and characterization of nitrate reductase-deficient mutants in tomato (Lycopersicon esculentum Mill.). Molecular & general genetics : MGG 1991. link
2 Sakuma R, Nishina T, Kitamura M, Yamanaka H, Kamatani N, Nishioka K. Screening for adenine and hypoxanthine phosphoribosyltransferase deficiencies in human erythrocytes by high-performance liquid chromatography. Clinica chimica acta; international journal of clinical chemistry 1987. link90138-0)
3 Ferrario S, Hirel B, Gadal P. Immuno chemical characterization of nitrate reductase from spinach leaves and roots. Biochemical and biophysical research communications 1983. link91060-4)
4 O'Toole TE, Wilson JM, Gault MH, Kelley WN. Human adenine phosphoribosyltransferase: characterization from subjects with a deficiency of enzyme activity. Biochemical genetics 1983. link
5 Krueger RJ, Siegel LM. Spinach siroheme enzymes: Isolation and characterization of ferredoxin-sulfite reductase and comparison of properties with ferredoxin-nitrite reductase. Biochemistry 1982. link